5d
GlobalData on MSNGSK’s Penmenvy meningococcal vaccine gains FDA approvalGSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...
Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings to GSK extensive expertise in immunology and ...
The government must invest in long-term renewable energy if it wants to driv (AI) growth in the East of England, experts have ...
GSK and Immunocore hope the TCRs can prove to ... anticipated to gain approval in late 2017/ early 2018. The privately-held, Oxford-based company says ImmTAC molecules offer a huge competitive ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...
GlaxoSmithKline wants to sell more than a ... the heart of the UK's 'golden triangle', extending between London, Oxford and Cambridge, which houses the lion's share of the country's life science ...
February 19, 2025 expert reaction to the announcement of the expansion of the OpenSAFELY data platform . Scientists comment on the expansion of the OpenSAFELY data platform. Prof ...
Dr. Screaton, currently Head of the Medical (TASE:BLWV) Sciences Division at the University of Oxford, will replace Dr. Jesse Goodman, who retires following nine years of service. Dr. Screaton brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results